levofloxacin has been researched along with pidotimod in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (pidotimod) | Trials (pidotimod) | Recent Studies (post-2010) (pidotimod) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 122 | 36 | 47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasi, F; Centanni, S; Clerici, M; Garziano, M; Mantero, M; Trabattoni, D | 1 |
1 trial(s) available for levofloxacin and pidotimod
| Article | Year |
|---|---|
Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Female; Hospitalization; Humans; Immunity, Innate; Immunologic Factors; Levofloxacin; Male; Middle Aged; Pneumonia; Prospective Studies; Pyrrolidonecarboxylic Acid; Thiazolidines; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |